Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
77 1.3% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
 |
BridgeBio PharmaBBIO |
93 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Oct 2024 | 57 | |
| Sep 2024 | 63 | |
| Aug 2024 | 64 | |
| Jul 2024 | 65 |
How do employees feel about the future at Gilead Sciences?
The Business Outlook at Gilead Sciences is neutral, according to employees. The average rating, aggregated from the top review sites in the US, of 57 out of 100 is decent.
Analyzing Business Outlook, how is Gilead Sciences performing compared to its industry peers?
Compared to its peers, Gilead Sciences ranks in the 57th percentile when it comes to Business Outlook.
How has the business outlook at Gilead Sciences changed over the last couple of months
In recent months, Gilead Sciences' employees have reported a shift towards a more negative business outlook, suggesting declining company morale and potentially leading to decreased market competitiveness and diminished company performance.
Why is it important to track the business outlook at Gilead Sciences?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Gilead Sciences.
